Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by pidukson Jun 28, 2024 7:32pm
140 Views
Post# 36111659

Why the CEO is BIG risk to LABS

Why the CEO is BIG risk to LABSLarge pharmaceutical companies in the United States are already FDA approved and if they have Canadian subsidiary operations those are approved by Health Canada.  In Canada cannabinoids are legal at the Federal level be it pharmaceutical or recreational.

The recent rescheduling of Cannabis in the U.S. from the strickest classification of Schedule 3 (has pharmaceutical applications) vastly changes the landscape for Medipharm Labs.

So to be blunt and frank, who the f""K needs Medipharm Labs?  Their DEL for cananbinoids is growing less valuable by the minute.

And you think the CEO has done a good job?  Get your ostrich heads out of the sand.  
<< Previous
Bullboard Posts
Next >>